Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.12% | 21.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.12% | 21.72% | |||
| Cost of Revenue | 2.12% | 32.38% | |||
| Gross Profit | 2.12% | 16.27% | |||
| SG&A Expenses | 2.12% | -9.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 2.11% | -12.33% | |||
| Total Operating Expenses | 2.12% | 4.84% | |||
| Operating Income | -2.13% | 35.68% | |||
| Income Before Tax | -2.12% | 34.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.12% | 34.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.12% | 34.59% | |||
| EBIT | -2.13% | 35.68% | |||
| EBITDA | -2.11% | 71.42% | |||
| EPS Basic | -2.33% | 44.16% | |||
| Normalized Basic EPS | -3.70% | 43.75% | |||
| EPS Diluted | -2.33% | 44.16% | |||
| Normalized Diluted EPS | -3.70% | 43.75% | |||
| Average Basic Shares Outstanding | 0.00% | 15.51% | |||
| Average Diluted Shares Outstanding | 0.00% | 15.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||